Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Andrews

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|January 7, 2012
Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug designMiles Congreve, Stephen P Andrews, Andrew S Doré, et al.
Journal of Medicinal Chemistry|December 14, 2022
The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool MoleculesTimothy P C Rooney, Gregory G Aldred, Helen K Boffey, et al.
Journal of Medicinal Chemistry|February 11, 2022
Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding ModeHelen K Boffey, Timothy P C Rooney, Henriette M G Willems, et al.
Nature|April 26, 2016
Extra-helical binding site of a glucagon receptor antagonistAli Jazayeri, Andrew S Doré, Daniel Lamb, et al.
Nature|July 13, 2017
Corrigendum: Crystal structure of the GLP-1 receptor bound to a peptide agonistAli Jazayeri, Mathieu Rappas, Alastair J H Brown, et al.
Nature|June 1, 2017
Crystal structure of the GLP-1 receptor bound to a peptide agonistAli Jazayeri, Mathieu Rappas, Alastair J H Brown, et al.
Neuron|March 11, 2017
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic OpportunitiesFiona M Menzies, Angeleen Fleming, Andrea Caricasole, et al.
Bioorganic & Medicinal Chemistry Letters|August 27, 2019
Identification of a novel allosteric GLP-1R antagonist HTL26119 using structure- based drug designAlistair O'Brien, Stephen P Andrews, Asma H Baig, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|January 7, 2012
Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug designMiles Congreve, Stephen P Andrews, Andrew S Doré, et al.
Journal of Medicinal Chemistry|December 14, 2022
The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool MoleculesTimothy P C Rooney, Gregory G Aldred, Helen K Boffey, et al.
Journal of Medicinal Chemistry|February 11, 2022
Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding ModeHelen K Boffey, Timothy P C Rooney, Henriette M G Willems, et al.
Nature|April 26, 2016
Extra-helical binding site of a glucagon receptor antagonistAli Jazayeri, Andrew S Doré, Daniel Lamb, et al.
Nature|July 13, 2017
Corrigendum: Crystal structure of the GLP-1 receptor bound to a peptide agonistAli Jazayeri, Mathieu Rappas, Alastair J H Brown, et al.
Nature|June 1, 2017
Crystal structure of the GLP-1 receptor bound to a peptide agonistAli Jazayeri, Mathieu Rappas, Alastair J H Brown, et al.
Neuron|March 11, 2017
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic OpportunitiesFiona M Menzies, Angeleen Fleming, Andrea Caricasole, et al.
Bioorganic & Medicinal Chemistry Letters|August 27, 2019
Identification of a novel allosteric GLP-1R antagonist HTL26119 using structure- based drug designAlistair O'Brien, Stephen P Andrews, Asma H Baig, et al.
Pageof 3